Literature DB >> 24275298

Failure of the fontan circulation.

Marc Gewillig1, David J Goldberg.   

Abstract

The essence of a Fontan circuit is the creation of the Fontan "neoportal system," which allows for oxygenation at near normal levels, but at the cost of a chronic state of systemic venous congestion and decreased cardiac output. The heart, while still the engine of the circuit, cannot compensate for this major flow restriction: the ventricle has lost control of the output and venous congestion. Systolic and diastolic ventricular dysfunction may aggravate the hemodynamic burden. The abnormal hemodynamics affects organs outside the heart and may lead to liver cirrhosis/malignancy, protein-losing enteropathy, or plastic bronchitis. The chronic low flow state causes an increase of pulmonary (and systemic) vascular resistance and ventricular filling pressures, causing failure of the Fontan to be progressive with increasing functional impairment.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chronic low output; Circulatory failure; Fontan circulation; Pulmonary vascular resistance

Mesh:

Year:  2014        PMID: 24275298     DOI: 10.1016/j.hfc.2013.09.010

Source DB:  PubMed          Journal:  Heart Fail Clin        ISSN: 1551-7136            Impact factor:   3.179


  46 in total

1.  Partial cavopulmonary assist from the inferior vena cava to the pulmonary artery improves hemodynamics in failing Fontan circulation: a theoretical analysis.

Authors:  Shuji Shimizu; Toru Kawada; Dai Une; Masafumi Fukumitsu; Michael James Turner; Atsunori Kamiya; Toshiaki Shishido; Masaru Sugimachi
Journal:  J Physiol Sci       Date:  2015-11-06       Impact factor: 2.781

Review 2.  Evaluating the Longevity of the Fontan Pathway.

Authors:  John M Kelly; Gabriel J M Mirhaidari; Yu-Chun Chang; Toshiharu Shinoka; Christopher K Breuer; Andrew R Yates; Kan N Hor
Journal:  Pediatr Cardiol       Date:  2020-11-08       Impact factor: 1.655

Review 3.  Balancing a single-ventricle circulation: 'physiology to therapy'.

Authors:  Rohan Magoon; Neeti Makhija; Surendra Kumar Jangid
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2020-01-02

Review 4.  Heart failure in single right ventricle congenital heart disease: physiological and molecular considerations.

Authors:  Anastacia M Garcia; Jonathan-Thomas Beatty; Stephanie J Nakano
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-02-28       Impact factor: 4.733

Review 5.  Congenital Heart Disease and the Liver.

Authors:  Moira B Hilscher; Patrick S Kamath
Journal:  Clin Liver Dis (Hoboken)       Date:  2019-11-06

6.  Modular design of a tissue engineered pulsatile conduit using human induced pluripotent stem cell-derived cardiomyocytes.

Authors:  Jinkyu Park; Christopher W Anderson; Lorenzo R Sewanan; Mehmet H Kural; Yan Huang; Jiesi Luo; Liqiong Gui; Muhammad Riaz; Colleen A Lopez; Ronald Ng; Subhash K Das; Juan Wang; Laura Niklason; Stuart G Campbell; Yibing Qyang
Journal:  Acta Biomater       Date:  2019-10-19       Impact factor: 8.947

Review 7.  Design and rationale of the Fontan Udenafil Exercise Longitudinal (FUEL) trial.

Authors:  David J Goldberg; Victor Zak; Bryan H Goldstein; Brian W McCrindle; Shaji C Menon; Kurt R Schumacher; R Mark Payne; Jonathan Rhodes; Kimberly E McHugh; Daniel J Penny; Felicia Trachtenberg; Michelle S Hamstra; Marc E Richmond; Peter C Frommelt; Matthew D Files; James L Yeager; Victoria L Pemberton; Mario P Stylianou; Gail D Pearson; Stephen M Paridon
Journal:  Am Heart J       Date:  2018-04-03       Impact factor: 4.749

Review 8.  Emerging clinical applications of strain imaging and three-dimensional echocardiography for the assessment of ventricular function in adult congenital heart disease.

Authors:  Michael Huntgeburth; Ingo Germund; Lianne M Geerdink; Narayanswami Sreeram; Floris E A Udink Ten Cate
Journal:  Cardiovasc Diagn Ther       Date:  2019-10

9.  Results of the FUEL Trial.

Authors:  David J Goldberg; Victor Zak; Bryan H Goldstein; Kurt R Schumacher; Jonathan Rhodes; Daniel J Penny; Christopher J Petit; Salil Ginde; Shaji C Menon; Seong-Ho Kim; Gi Beom Kim; Todd T Nowlen; Michael V DiMaria; Benjamin P Frischhertz; Jonathan B Wagner; Kimberly E McHugh; Brian W McCrindle; Amanda J Shillingford; Arash A Sabati; Anji T Yetman; Anitha S John; Marc E Richmond; Matthew D Files; R Mark Payne; Andrew S Mackie; Christopher K Davis; Shabana Shahanavaz; Kevin D Hill; Ruchira Garg; Jeffrey P Jacobs; Michelle S Hamstra; Stacy Woyciechowski; Kathleen A Rathge; Michael G McBride; Peter C Frommelt; Mark W Russell; Elaine M Urbina; James L Yeager; Victoria L Pemberton; Mario P Stylianou; Gail D Pearson; Stephen M Paridon
Journal:  Circulation       Date:  2019-11-17       Impact factor: 29.690

10.  Exercise Capacity and Predictors of Performance After Fontan: Results from the Pediatric Heart Network Fontan 3 Study.

Authors:  David J Goldberg; Victor Zak; Brian W McCrindle; Hua Ni; Russell Gongwer; Jonathan Rhodes; Robert P Garofano; Jonathan R Kaltman; Linda M Lambert; Lynn Mahony; Renee Margossian; Zebulon Z Spector; Richard V Williams; Andrew M Atz; Stephen M Paridon
Journal:  Pediatr Cardiol       Date:  2020-09-25       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.